ARS Pharmaceuticals Inc (NASDAQ:SPRY)
| 6.33 Delayed Data As of Jan 30 |  +0.01 / +0.16%Today’s Change | 2.80 Today|||52-Week Range 9.17 | -25.79% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Shawver Laura K Chief Executive Officer |  Buy | 8/05/2022 | 78,740 | $1.27 | $100.0K | +21.92% |
Odegard Valerie President & Chief Scientific Officer | Gift | 2/01/2022 | 16,406 | $0.00 | $0.00 | +30.72% |
Shawver Laura K Chief Executive Officer | Gift | 2/01/2022 | 27,500 | $0.00 | $0.00 | +30.72% |
Hunder Naomi Chief Medical Officer | Gift | 2/01/2022 | 11,250 | $0.00 | $0.00 | +30.72% |
Piazza Jonathan Chief Financial Officer | Gift | 2/01/2022 | 11,250 | $0.00 | $0.00 | +30.72% |
Hawkinson Russell Senior Vice President-Finance | Gift | 2/01/2022 | 7,500 | $0.00 | $0.00 | +30.72% |
Hawkinson Russell Senior Vice President-Finance | Gift | 5/02/2022 | 28,335 | $0.00 | $0.00 | +101.27% |
Hunder Naomi Chief Medical Officer | Gift | 5/02/2022 | 43,177 | $0.00 | $0.00 | +101.27% |
Odegard Valerie President & Chief Scientific Officer | Gift | 5/02/2022 | 45,233 | $0.00 | $0.00 | +101.27% |
Piazza Jonathan Chief Financial Officer | Gift | 5/02/2022 | 43,691 | $0.00 | $0.00 | +101.27% |
Page of 2